Skip to main content

Cambridge Advisors Inc.

SEC CIK
0001633695
Latest filing
Jul 16, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Cambridge Advisors Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
8,520
Value
$2.14M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Cambridge Advisors Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,520$2.14M0.4%−40−0.5%ReducedHolders
Q1 20268,560$1.86M0.4%−45−0.5%ReducedHolders
Q4 20258,605$1.97M0.4%−15−0.2%ReducedHolders
Q3 20258,620$2.00M0.4%−82−0.9%ReducedHolders
Q2 20258,702$1.62M0.3%−18−0.2%ReducedHolders
Q1 20258,720$1.83M0.4%−159−1.8%ReducedHolders
Q4 20248,879$1.58M0.4%+104+1.2%AddedHolders
Q3 20248,775$1.73M0.4%−65−0.7%ReducedHolders
Q2 20248,840$1.52M0.4%+65+0.7%AddedHolders
Q1 20248,775$1.60M0.4%−600−6.4%ReducedHolders
Q4 20239,375$1.45M0.4%−200−2.1%ReducedHolders
Q3 20239,575$1.43M0.4%−505−5.0%ReducedHolders
Q2 202310,080$1.36M0.3%−1,085−9.7%ReducedHolders
Q1 202311,165$1.78M0.5%+50+0.4%AddedHolders
Q4 202211,115$1.80M0.5%−350−3.1%ReducedHolders
Q3 202211,465$1.54M0.4%−50−0.4%ReducedHolders
Q2 202211,515$1.76M0.5%−233−2.0%ReducedHolders
Q1 202211,748$1.90M0.5%−37−0.3%ReducedHolders
Q4 202111,785$1.60M0.4%+400+3.5%AddedHolders
Q3 202111,385$1.23M0.3%−231−2.0%ReducedHolders
Q2 202111,616$1.31M0.3%−274−2.3%ReducedHolders
Q1 202111,890$1.29M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.